Levamisole is used in IHC to block endogenous alkaline phosphatase activity in combination with chromogen, except for intestinal alkaline phosphatase.

To block endogenous ALP in all tissues.

In combination with chromogen to block endogenous ALP except intestinal ALP.

Endogenous alkaline phosphatase can cause unwanted background staining when using an alkaline phosphatase–based detection system. Levamisole is added to the chromogen solution to inhibit most of this endogenous ALP activity, thereby reducing background. A key detail is that intestinal alkaline phosphatase is not inhibited by levamisole, so tissues containing intestinal ALP may still show some background. This is why the statement describes blocking endogenous ALP except for intestinal ALP. It’s not used as a primary antibody diluent or as a mounting medium, and it doesn’t block ALP in all tissues.

As a primary antibody diluent.

As a mounting medium.

Want more questions?

All options are one-time payments.

$25.99

30 day pass for new members

All the basics to get you started

  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 30 day premium pass access
$59.99$171.99 usd

6 month DELUXE pass (most popular)

Full access FOR 6 MONTHS! & the ultimate digital PDF study guide (BONUS)

  • $171.99 usd value for $59.99! You save $106!
  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 6 months of full access
  • Ultimate digital PDF study guide included
  • Priority support
$15.99 $24.99

Ultimate digital PDF study guide

For those that prefer a more traditional form of learning

  • Available for instant download
  • Available offline
  • Hundreds of practice multiple choice questions
  • Comprehensive content
  • Detailed explanations
Image Description
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy